Stoke Therapeutics Inc (NASDAQ:STOK)

13.74
Delayed Data
As of Jul 01
 +0.56 / +4.24%
Today’s Change
9.55
Today|||52-Week Range
34.83
-42.73%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2017

2018

--

--
AssetsCash1.8M105.4M----
 
 
 
Short Term Investment Cash477.0K103.8M----
 
 
 
Cash & Short Term Investments1.8M105.4M----
 
 
 
 
ReceivablesReceivables0.00196.0K----
 
 
 
InventoriesInventories0.000.00------
 
Current AssetsOther Current Assets113.0K548.0K----
 
 
 
Current Assets1.9M106.1M----
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross645.0K1.6M----
 
 
 
Depreciation-172.0K-379.0K----
 
 
 
Other Assets0.000.00------
Total Assets2.4M107.5M----
 
 
 
 
LiabilitiesAccounts Payable141.0K1.1M----
 
 
 
Short Term Debt3.0M0.00----
 
 
Accrued Expenses192.0K495.0K----
 
 
 
Other Current Liabilities192.0K495.0K----
 
 
 
Other Liabilities3.7M2.5M----
 
 
 
 
Total LiabilitiesOther Liabilities16.0K4.0K----
 
 
 
Total Liabilities3.7M2.5M----
 
 
 
 
EquityMinority Interest0.000.00------
Preferred Stock5.0K23.0K----
 
 
 
Common Equity-1.3M105.0M----
 
 
 
Total Shareholder Equity-1.3M105.1M----
 
 
 
 
Share InformationCommon Shares Outstanding31.3M31.3M----
 
 
 
 
Addtl. Info.No data currently available for this section.